Literature DB >> 25284494

Spontaneous remission of acute myeloid leukemia.

Armin Rashidi1, Stephen I Fisher.   

Abstract

Spontaneous remission (SR) of acute myeloid leukemia (AML) is rare. We collected all 46 reported cases of AML with SR. Fever occurred in 91.3% of cases before remission, which was largely due to pneumonia (54.5%) and bacteremia (24.2%). Pneumonia and bacteremia were significantly more common among those who achieved complete remission (CR) compared to those who achieved only a partial remission (p = 0.032). Although 88.6% of remissions were CR, the median duration of remission was only 5 months. Eight cases did not relapse during the follow-up period. The mechanism of SR in AML likely involves the stimulatory effect of systemic febrile infection on the immune system. Immediate treatment of infections and fever may contribute to the rarity of SR in AML. The results of this review improve our understanding of the important role of the immune system in countermanding AML and may provide new ideas for immunotherapy.

Entities:  

Keywords:  Leukemia; myeloid; remission; spontaneous

Mesh:

Year:  2014        PMID: 25284494     DOI: 10.3109/10428194.2014.970545

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  15 in total

1.  Patients with spontaneous remission of high-risk MDS and AML show persistent preleukemic clonal hematopoiesis.

Authors:  Victoria V Grunwald; Marcus Hentrich; Xaver Schiel; Annika Dufour; Stephanie Schneider; Michaela Neusser; Marion Subklewe; Michael Fiegl; Wolfgang Hiddemann; Karsten Spiekermann; Maja Rothenberg-Thurley; Klaus H Metzeler
Journal:  Blood Adv       Date:  2019-09-24

Review 2.  Alterations of T-cell-mediated immunity in acute myeloid leukemia.

Authors:  Zhuoyan Li; Mary Philip; P Brent Ferrell
Journal:  Oncogene       Date:  2020-03-03       Impact factor: 9.867

3.  Spontaneous molecular response of IDH2 acute myeloid leukemia.

Authors:  Sabine Khalife-Hachem; Jean Pegliasco; Véronique Saada; Eric Hernandez; Valerie Camara-Clayette; Sophie Cotteret; Raouf Benabdelali; Stephane de Botton; Christophe Marzac; Jean-Baptiste Micol
Journal:  Ann Hematol       Date:  2019-12-09       Impact factor: 4.030

4.  Spontaneous Remission in an Older Patient with Relapsed FLT3 ITD Mutant AML.

Authors:  Pankit Vachhani; Jason H Mendler; Andrew Evans; George Deeb; Petr Starostik; Paul K Wallace; Eunice S Wang
Journal:  Case Rep Hematol       Date:  2016-12-29

5.  Spontaneous Complete Remission in a Patient with Acute Myeloid Leukemia and Severe Sepsis.

Authors:  Rambod Mozafari; Mahsa Moeinian; Ali Asadollahi-Amin
Journal:  Case Rep Hematol       Date:  2017-07-24

6.  Spontaneous remission of acute myeloid leukemia with NF1 alteration.

Authors:  Terrence Bradley; Radames Adamo Zuquello; Luis E Aguirre; Nicholas Mackrides; Jennifer Chapman; Luisa Cimmino; Amber Thomassen; Justin Watts
Journal:  Leuk Res Rep       Date:  2020-05-16

7.  Spontaneous remission of acute monocytic leukemia with trisomy 8 and trisomy 18.

Authors:  Takahiro Suyama; Kaoru Hasebe
Journal:  J Clin Exp Hematop       Date:  2019

8.  Spontaneous Remission in a Patient With Acute Myeloid Leukemia Leading to Undetectable Minimal Residual Disease.

Authors:  Daniel Helbig; Andres E Quesada; Wenbin Xiao; Mikhail Roshal; Martin S Tallman; David A Knorr
Journal:  J Hematol       Date:  2020-04-23

9.  Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy.

Authors:  Zhongbo Hu; Kristen A VanHeyst; Jignesh Dalal; Lisa Hackney
Journal:  Clin Case Rep       Date:  2021-02-12

Review 10.  Spontaneous Regression of Blastic Plasmacytoid Dendritic Cell Neoplasm Following Sepsis by Serratia marcescens: A Case Report and Literature Review.

Authors:  Akane Suzuki; Shori Abe; Kaori Koyama; Shinju Suzuki; Munenori Nagao; Masahiro Kobayashi; Jun Nomura; Tomomi Tsutsumi; Tomoki Takeda; Yumiko Oka; Yuko Shirota; Naruhiko Takasawa; Takao Kodera; Yoko Okitsu; Shinichiro Takahashi; Ryo Ichinohasama; Junichi Kameoka
Journal:  Intern Med       Date:  2021-03-15       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.